Mark C. Glaum

523 total citations
21 papers, 389 citations indexed

About

Mark C. Glaum is a scholar working on Physiology, Immunology and Immunology and Allergy. According to data from OpenAlex, Mark C. Glaum has authored 21 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Immunology and 6 papers in Immunology and Allergy. Recurrent topics in Mark C. Glaum's work include Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (4 papers) and Mast cells and histamine (4 papers). Mark C. Glaum is often cited by papers focused on Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (4 papers) and Mast cells and histamine (4 papers). Mark C. Glaum collaborates with scholars based in United States. Mark C. Glaum's co-authors include Richard F. Lockey, Edward S. Schulman, Donald G. Raible, Mathew Varghese, Joseph H. Butterfield, Jonathan S. Jaffe, Joy G. Mohanty, T J Post, Amir Pelleg and Yihe Wang and has published in prestigious journals such as Free Radical Biology and Medicine, Journal of Allergy and Clinical Immunology and Allergy.

In The Last Decade

Mark C. Glaum

20 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C. Glaum United States 10 175 160 120 59 57 21 389
Erika Méndez-Enríquez Sweden 8 163 0.9× 208 1.3× 81 0.7× 8 0.1× 43 0.8× 15 390
Kumiko Fujisawa Japan 5 66 0.4× 159 1.0× 48 0.4× 119 2.0× 9 0.2× 5 334
Jonathan Lam United States 10 185 1.1× 244 1.5× 59 0.5× 8 0.1× 46 0.8× 10 425
Anne Kagey-Sobotka United States 12 473 2.7× 276 1.7× 537 4.5× 57 1.0× 101 1.8× 13 816
Sangeeta Kumari India 7 56 0.3× 215 1.3× 60 0.5× 8 0.1× 19 0.3× 30 420
Ayako Kaitani Japan 12 78 0.4× 326 2.0× 88 0.7× 21 0.4× 10 0.2× 22 454
A. Paige Davis Volk United States 8 196 1.1× 241 1.5× 68 0.6× 5 0.1× 88 1.5× 8 454
Rachael Huff United States 7 386 2.2× 350 2.2× 52 0.4× 6 0.1× 136 2.4× 8 608
Haiyin Xiao United States 5 300 1.7× 210 1.3× 109 0.9× 2 0.0× 97 1.7× 9 424
Kazumi Kasakura Japan 15 123 0.7× 291 1.8× 86 0.7× 4 0.1× 16 0.3× 33 483

Countries citing papers authored by Mark C. Glaum

Since Specialization
Citations

This map shows the geographic impact of Mark C. Glaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Glaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Glaum more than expected).

Fields of papers citing papers by Mark C. Glaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Glaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Glaum. The network helps show where Mark C. Glaum may publish in the future.

Co-authorship network of co-authors of Mark C. Glaum

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Glaum. A scholar is included among the top collaborators of Mark C. Glaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Glaum. Mark C. Glaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raasch, Jason, et al.. (2023). The multifactorial impact of receiving a hereditary angioedema diagnosis. World Allergy Organization Journal. 16(6). 100792–100792. 13 indexed citations
2.
Pepper, Amber N., Panida Sriaroon, & Mark C. Glaum. (2020). Additives and preservatives: Role in food allergy. PubMed. 2(1). 119–123. 6 indexed citations
3.
Glaum, Mark C., et al.. (2017). A Case of Common Variable Immunodeficiency (CVID) and Antineutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis. Journal of Allergy and Clinical Immunology. 139(2). AB19–AB19. 2 indexed citations
4.
Glaum, Mark C., et al.. (2016). Symptomatic Primary Selective Immunoglobulin M Deficiency with Nonprotective Pneumococcal Titers Responsive to Subcutaneous Immunoglobulin Treatment. International Archives of Allergy and Immunology. 170(2). 138–140. 5 indexed citations
5.
Glaum, Mark C., et al.. (2014). Osteoporosis in the at-risk asthmatic. Allergy. 69(11). 1429–1439. 19 indexed citations
6.
Glaum, Mark C., et al.. (2014). Real-Time PCR Quantification Of Virginia Live Oak (Quercus virginiana) Pollen. Journal of Allergy and Clinical Immunology. 133(2). AB18–AB18. 1 indexed citations
7.
Lockey, Richard F., et al.. (2011). Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. Allergy and Asthma Proceedings. 32(4). 288–294. 31 indexed citations
8.
Varghese, Mathew, Mark C. Glaum, & Richard F. Lockey. (2010). Drug‐induced rhinitis. Clinical & Experimental Allergy. 40(3). 381–384. 51 indexed citations
9.
Kumar, Arun, Mark C. Glaum, Nagwa El‐Badri, et al.. (2010). Initial Observations of Cell-Mediated Drug Delivery to the Deep Lung. Cell Transplantation. 20(5). 609–618. 23 indexed citations
10.
Kim, Dennis, Mark C. Glaum, & Richard Lockey. (2009). Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma. Expert Opinion on Drug Metabolism & Toxicology. 5(8). 933–940. 4 indexed citations
11.
Glaum, Mark C., et al.. (2009). Mediator Release from a New Human Mast Cell Line (USF-MC1). Journal of Allergy and Clinical Immunology. 123(2). S197–S197. 1 indexed citations
12.
Glaum, Mark C., Decheng Song, Yi Zheng, et al.. (2008). Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production. Journal of Allergy and Clinical Immunology. 123(1). 224–230.e4. 46 indexed citations
13.
Glaum, Mark C., et al.. (2008). Identification of a Stable Human Mast Line Derived from Human Cord Blood Stem Cells. Journal of Allergy and Clinical Immunology. 121(2). S216–S216. 1 indexed citations
14.
Chacko, Thomas, Mark C. Glaum, Dennis K. Ledford, Roger W. Fox, & Richard F. Lockey. (2007). Systemic Reactions to Percutaneous (P) and Intradermal (ID) Skin Tests (ST). Journal of Allergy and Clinical Immunology. 119(1). S58–S58. 2 indexed citations
15.
Glaum, Mark C., et al.. (2001). Degranulation influences heparin‐associated inhibition of RT‐PCR in human lung mast cells. Clinical & Experimental Allergy. 31(10). 1631–1635. 4 indexed citations
16.
Raible, Donald G., et al.. (2000). Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation. Free Radical Biology and Medicine. 28(11). 1652–1660. 12 indexed citations
17.
Schulman, Edward S., Mark C. Glaum, Yihe Wang, et al.. (1999). ATP Modulates Anti-IgE–Induced Release of Histamine from Human Lung Mast Cells. American Journal of Respiratory Cell and Molecular Biology. 20(3). 530–537. 78 indexed citations
18.
Jaffe, Jonathan S., Donald G. Raible, T J Post, et al.. (1996). Human Lung Mast Cell Activation Leads to IL-13 mRNA Expression and Protein Release. American Journal of Respiratory Cell and Molecular Biology. 15(4). 473–481. 30 indexed citations
19.
Jaffe, Jonathan S., Mark C. Glaum, Donald G. Raible, et al.. (1995). Human Lung Mast Cell IL-5 Gene and Protein Expression: Temporal Analysis of Upregulation Following IgE-Mediated Activation. American Journal of Respiratory Cell and Molecular Biology. 13(6). 665–675. 49 indexed citations
20.
Glaum, Mark C., Jonathan S. Jaffe, David Gillespie, et al.. (1995). IgE-Dependent Expression of Interleukin-5 mRNA and Protein in Human Lung: Modulation by Dexamethasone. PubMed. 75(2). 171–178. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erika Méndez-Enríquez Breakdown of academic impact, for papers by Kumiko Fujisawa Breakdown of academic impact, for papers by Jonathan Lam Breakdown of academic impact, for papers by Anne Kagey-Sobotka Breakdown of academic impact, for papers by Sangeeta Kumari Breakdown of academic impact, for papers by Ayako Kaitani Breakdown of academic impact, for papers by A. Paige Davis Volk Breakdown of academic impact, for papers by Rachael Huff Breakdown of academic impact, for papers by Haiyin Xiao Breakdown of academic impact, for papers by Kazumi Kasakura
Rankless by CCL
2026